HHS shutters clinical guidance resource; ECRI Institute says it will launch a replacement

White House
The Trump administration shut down a key clinical guidelines website on Monday. (Pixabay)

The Trump administration shut down a key clinical guidelines website on Monday, and industry experts have decried the move.

The Department of Health and Human Services revealed on May 14 that it intended to close to the National Guideline Clearinghouse, a part of the Agency for Healthcare Research and Quality (AHRQ), and posted a second notice last week to reiterate the decision. 

Budget concerns at AHRQ were cited as the main reason for shutting down the site, which offers clinical guidelines about countless conditions and sees more than 200,000 visitors per month.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

"The difficult decision to shutter the NGC was made by AHRQ's leadership in response to our current budget, and the expiration of funding that supported the NGC," Alison Hunt, AHRQ spokesperson, told FierceHealthcare.

Hunt said AHRQ will keep a backup of the data previously housed in the NGC, and is "exploring options" to sustain the clearinghouse.

AHRQ has been a target for cost-cutting efforts in the Trump White House, which proposed shuttering the agency entirely. 

RELATED: Agency for Healthcare Research and Quality a potential casualty of Trump budget cuts 

Leading figures in the industry have slammed the decision on social media since the second notice was posted last week.

Atul Gawande, M.D., a famed surgeon and author who has been tapped to head Amazon, JPMorgan Chase and Berkshire Hathaway's healthcare venture, said closing the clearinghouse is an "astonishing and unconscionable blow for access to scientific information." 

Valerie King, M.D., director of research at the Center for Evidence Based Policy at Oregon Health and Science University, said in a tweet that eliminating the NGC is "saving pennies to cost millions." 

"There's a whole lotta scrambling to save/recreate something that would have taken pennies to maintain," King said in a second tweet. 

RELATED: Decline in hospital-acquired infections saved 8,000 lives and $2.9B, AHRQ says 

In response to the NGC shutdown, the medical community has launched petitions to reinstate it and has been teaming with volunteers to clone the site.  

In addition, ECRI Institute, an independent nonprofit that built and maintained the clearinghouse, announced Tuesday that it would continue to provide clinical guidelines. 

The institute said it will launch a guidance resource that houses "current, properly vetted evidence-based clinical practice guideline summaries and other information." The first version of the resource site will allow clinicians to search ECRI summaries of available guidance and will be updated to be more user-friendly and offer decision-making support. 

"Not all guidelines are created equal. Clinicians want to know what stands behind a particular recommendation, and whether they can trust that recommendation," Jane Jue, M.D., ECRI's medical director, said in the announcement. "Trustworthy guidance is the real value we will be providing." 

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Policy changes are affecting how investors view the skilled home health market and paving the way for potential strategic acquisitions.